[go: up one dir, main page]

ES2575234B1 - Equipo de suministro de insulina no invasivo - Google Patents

Equipo de suministro de insulina no invasivo Download PDF

Info

Publication number
ES2575234B1
ES2575234B1 ES201531400A ES201531400A ES2575234B1 ES 2575234 B1 ES2575234 B1 ES 2575234B1 ES 201531400 A ES201531400 A ES 201531400A ES 201531400 A ES201531400 A ES 201531400A ES 2575234 B1 ES2575234 B1 ES 2575234B1
Authority
ES
Spain
Prior art keywords
invasive
insulin
equipment
insulin delivery
apply
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES201531400A
Other languages
English (en)
Other versions
ES2575234A1 (es
Inventor
Joaquín BUSTELO DE LA QUINTANA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DISPOSITIVOS NO INVASIVOS PARA DIAGNOSIS S L
DISPOSITIVOS NO INVASIVOS PARA DIAGNOSIS SL
Original Assignee
DISPOSITIVOS NO INVASIVOS PARA DIAGNOSIS S L
DISPOSITIVOS NO INVASIVOS PARA DIAGNOSIS SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DISPOSITIVOS NO INVASIVOS PARA DIAGNOSIS S L, DISPOSITIVOS NO INVASIVOS PARA DIAGNOSIS SL filed Critical DISPOSITIVOS NO INVASIVOS PARA DIAGNOSIS S L
Priority to ES201531400A priority Critical patent/ES2575234B1/es
Publication of ES2575234A1 publication Critical patent/ES2575234A1/es
Application granted granted Critical
Publication of ES2575234B1 publication Critical patent/ES2575234B1/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813—Specially adapted to be attached to a specific body part
    • A61B5/6814—Head
    • A61B5/6815—Ear
    • A61B5/6817—Ear canal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Emergency Medicine (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

Equipo de suministro de insulina no invasivo#El equipo de la invención permite medir y calcular en tiempo real de forma no invasiva un perfil glucémico real a partir del cual aplicar igualmente de forma no invasiva, aportaciones de insulina, debidamente dosificadas y en los momentos concretos en los que la misma es necesaria, lo que redunda en una mejora sustancial en la calidad de vida para el diabético, no sufriendo ningún tipo de proceso invasivo.#Para ello, el equipo está constituido a partir de un sensor del nivel de glucemia (1) con un espectrofotómetro (5), una muñequera (2) con un display (16) para visualización de dichos niveles, y un cinturón (3) asociado a una bomba de insulina no invasiva (20), basada en la iontoforesis, que aplica la insulina por medio de dos electrodos (21) y (22) de forma automática e indolora.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8

Claims (1)

  1. imagen1
    imagen2
ES201531400A 2015-09-30 2015-09-30 Equipo de suministro de insulina no invasivo Expired - Fee Related ES2575234B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201531400A ES2575234B1 (es) 2015-09-30 2015-09-30 Equipo de suministro de insulina no invasivo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201531400A ES2575234B1 (es) 2015-09-30 2015-09-30 Equipo de suministro de insulina no invasivo

Publications (2)

Publication Number Publication Date
ES2575234A1 ES2575234A1 (es) 2016-06-27
ES2575234B1 true ES2575234B1 (es) 2017-04-05

Family

ID=56134735

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201531400A Expired - Fee Related ES2575234B1 (es) 2015-09-30 2015-09-30 Equipo de suministro de insulina no invasivo

Country Status (1)

Country Link
ES (1) ES2575234B1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5115133A (en) * 1990-04-19 1992-05-19 Inomet, Inc. Testing of body fluid constituents through measuring light reflected from tympanic membrane
CA2365609A1 (en) * 1999-02-12 2000-08-17 Cygnus, Inc. Devices and methods for frequent measurement of an analyte present in a biological system

Also Published As

Publication number Publication date
ES2575234A1 (es) 2016-06-27

Similar Documents

Publication Publication Date Title
MA54623A (fr) Système d'administration d'insuline répondant au glucose utilisant des nanocomposites sensibles à l'hypoxie
CY1120030T1 (el) Διπλοι glp1/gip ή τριγωνικοι αγωνιστες glp1/gip/ γλυκαγονης
Timmons et al. Inpatient glycemic variability and long-term mortality in hospitalized patients with type 2 diabetes
EA201491934A1 (ru) Аналоги глюкагоноподобного пептида-2 (glp-2)
ES2721635T3 (es) Generación de imágenes de biomarcadores para el diagnóstico del dolor de espalda
CO7131353A2 (es) Tratamiento de trastornos del ritmo circadiano
EA201590058A1 (ru) Аналоги глюкагона
UY36779A (es) Nuevos derivados de exendina-4 como agonistas peptídicos duales específicos de los receptores de glp-1 / glucagón
WO2016005586A3 (en) Titration of basal insulin with two modes
EP4233723A3 (en) Lancet device with first-drop removal
EA201700123A1 (ru) Способ прогнозирования варианта лекарственного препарата для лечения депрессии
CR20140473A (es) Compuestos de pirazol como inhibidores de sglt1
PH12017501290A1 (en) Treatment of pediatric type 2 diabetes mellitus patients with lixisenatide
CO6640324A2 (es) Uso de metformina en combinación con un activador de glucoquinasa y composiciones que comprenden metformina y un activador de glucoquinasa
EA201792030A1 (ru) Лечение пациентов с сахарным диабетом 2 типа
CL2016000641A1 (es) Un controlador para un dispositivo para administrar un medio de contraste que comprende un agente de contraste radiológico en un paciente usando un inyector, y método para determinar el volumen óptimo de un medio de contraste que comprende un agente de contraste radiológico que ha de administrarse en un paciente, antes de la administración.
ES2575234B1 (es) Equipo de suministro de insulina no invasivo
EA201591123A1 (ru) Комбинации агониста glp1r и метформина, а также способ их применения при лечении диабета 2 типа и прочих расстройств
CL2018001782A1 (es) Metodos y composiciones para el tratamiento del sindrome de hunter.
WO2015063366A8 (en) Methods and device arrangement for physical activity thresholds promoting fat and cholesterol metabolism in high risk subjects
MX2020007661A (es) Un bioensayo para la detección no invasiva del uso de drogas y afecciones fisiológicas.
Rizzo et al. Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012; 35: 2076–2082
So Optimising glycaemic control in older patients in Hong Kong
Chadha Interesting Case Conference
Saenko et al. Indices of cerebrovascular reactivity in patients with diabetes mellitus complicated with cardiovascular autonomic neuropathy

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2575234

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20170405

FD2A Announcement of lapse in spain

Effective date: 20211004